IntegriChain, a market leader in net revenue optimization technology and insights for the life sciences industry, today announced a strategic leadership evolution within its Product and Technology organization, underscoring the company’s commitment to innovation. Shai Fiss has been appointed as the new Chief AI and Technology Officer (CAIO & CTO), effective August 18, 2025. Concurrently, Brad Burget, the current Chief Technology Officer, will transition to the role of CTO Emeritus.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250818673172/en/
Shai Fiss - Chief AI and Technology Officer
The appointment of Shai Fiss signals a significant step in the company's strategy to develop and embed creative automation efficiencies across its platform to scale and rapidly meet customer needs. In his new role, Fiss will oversee the entire Product and Technology organization, with a focus on driving automation in customer net revenue workflows and commercial data management. He brings a strong background in building and scaling high-growth SaaS and enterprise platforms, as well as deep experience in AI adoption within product development and healthcare workflows.
“We are at a pivotal moment, with customers asking for our answers to the innovation explosion in AI,” said Josh Halpern, CEO of IntegriChain. “Shai's expertise will be instrumental in generating a new approach to embedding automation and guiding our next chapter of growth. His leadership will accelerate execution across the full product lifecycle while ensuring deep technical leadership remains at the core of our strategy”.
Shai Fiss shared his enthusiasm, stating, “I am passionate about transforming healthcare through intelligent, human-centered digital platforms. My mission is to advance and scale our core technologies to streamline operations, accelerate decision-making, and deliver next-generation digital experiences. I look forward to collaborating with the talented team to advance our technology platform, expand our product capabilities, and create greater value for our clients.”
Brad Burget, who has been with the company for over a decade, will leverage his extensive experience and skills in his new role as CTO Emeritus. He will concentrate on a key strategic initiative: the company’s channel transformation program. This refined focus will allow him to strengthen capabilities in this critical area, driving technical excellence and further embedding value with customers.
“Brad’s leadership contributions have been instrumental in our incredible progress and achievements, solidifying us as a market leader and innovator,” Halpern added. “We sincerely thank him for guiding our teams through rapid growth and the development of a strong, highly skilled team of professionals.”
Both leadership changes are effective August 18, 2025.
About Shai Fiss
Shai Fiss is a seasoned technology executive with hands-on experience in developing and deploying AI, ML/LLM, Ambient, and agentic SaaS platforms, with an emphasis on security, high availability, and scalability. He has over two decades of technology leadership, consistently driving innovation in cloud computing and AI to create scalable, secure, and user-centric solutions. Fiss has served as a four-time PE-backed executive with M&A experience in sectors including Hospitals, Pharmaceutical, Behavioral Health, and EHR. He is recognized for fostering a culture of innovation, driving top-line growth, and implementing cost-effective measures. His experience includes leading the conceptualization and execution of large-scale projects from startups to billion-dollar valuations, and successfully deploying offshore, nearshore, and local engineering teams.
About IntegriChain
IntegriChain is the leading provider of revenue optimization technology and insights for the Pharma industry. The company’s ICyte data-driven commercialization platform enables manufacturers to develop, implement, and operate sustainable growth strategies for life-changing science. Through its unique focus on data, SaaS and BPaaS technology, consulting, and outsourcing, IntegriChain helps manufacturers connect the commercial, financial, and operational dimensions of drug access – all the way from demand through to net revenue optimization. IntegriChain is backed by Nordic Capital, a leading sector-specialized private equity investor with a broad portfolio of Healthcare and Technology. IntegriChain is headquartered in Philadelphia, PA, with offices in Ambler, PA, and Pune, India. For more information, visit www.integrichain.com or follow on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250818673172/en/
“Shai's expertise will be instrumental in generating a new approach to embedding automation and guiding our next chapter of growth." Josh Halpern, CEO of IntegriChain
Contacts
Brandy Jensen | Director of Marketing | bjensen@integrichain.com